Abstract The transcription factor NF-jB family is central for osteoclastogenesis and inflammatory osteolysis. Activation of NF-jB dimers is regulated by a kinase complex predominantly containing IKKa (IKK1), IKKb (IKK2), and a regulatory subunit, IKKc/NEMO. IKKa and IKKb catalyze the cytoplasmic liberation and nuclear translocation of various NF-jB subunits. The requirement of IKKa and IKKb for normal bone homeostasis has been established. Congruently, mice devoid of IKKa or IKKb exhibit in vitro and in vivo defects in osteoclastogenesis, and IKKb-null mice are refractory to inflammatory arthritis and osteolysis. To better understand the molecular mechanism underlying IKKb function in bone homeostasis and bone pathologies, we conducted structure-function analysis to determine IKKb functional domains in osteoclasts. IKKb encompasses several domains, of which the ubiquitination-like domain (ULD) has been shown essential for IKKb activation. In this study, we examined the role of ULD in IKKb-mediated NFjB activation in osteoclast precursors and its contribution to osteoclastogenesis and osteolysis. We generated and virally introduced IKKb in which the ULD domain has been deleted (IKKbDULD) into osteoclast progenitors. The results show that deletion of ULD diminishes IKKb activity and that IKKbDULD strongly inhibits osteoclastogenesis. In addition, unlike wild type (WT)-IKKb, IKKbDULD fail to restore RANKL-induced osteoclastogenesis by IKKbnull precursors. Finally, we provide evidence that IKKb-DULD blocks inflammatory osteolysis in a model of murine calvarial osteolysis. Thus, we identified the ULD as crucial for IKKb activity and osteoclastogenesis and found that ULD-deficient IKKb is a potent inhibitor of osteoclastogenesis and osteolysis.
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Keywords IKKb Á Osteoclast Á Osteolysis Á Ubiquitin Osteoclasts are the predominant cells responsible for bone resorption and their bone resorptive activity is essential for maintaining bone homeostasis [1, 2] . However, certain genetic impairments, metabolic flaws, and environmental insults may negatively impact bone homeostasis by altering osteoclast activity. Among the most common disparities are age-related hormone imbalance and inflammatory responses [3, 4] . Therefore, understanding the mechanisms governing osteoclast development and activity have been and continue to be the focus of research efforts combating bone loss ailments.
In addition to its crucial role in osteoclast development and function [5] , the transcription factor family NF-jB has emerged in recent years as central mediator of inflammatory responses and osteolysis [4, 6, 7] . At the center of this family is the IKK complex comprised of the kinases IKKa, IKKb and the scaffold protein IKKc/NEMO [8] . The IKK complex forms in response to activation of transmembrane receptors by certain extra cellular stimuli. In this regard, inflammatory stimuli, such as LPS and TNF as well as the osteoclastogenic ligand RANKL activate their respective receptors leading to recruitment and activation of the IKK complex which in turn phosphorylates downstream inhibitory molecules leading to their proteosomal degradation. As a result, various NF-jB subunits, including p50, p52, p65, RelB, and c-Rel are released, shuttled to the nucleus where they activate transcription.
The role of NF-jB subunits and kinases in skeletal development has been described. Whereas combined deletion of p50 and p52 subunits of NF-jB arrested osteoclastogenesis and resulted in severe osteopetrosis, single deletions of others proteins in the pathway were mostly consistent with varying degrees of phenotypic severity [9] [10] [11] . Based on these studies, several approaches targeting NF-jB signal transduction were developed to alleviate inflammatory osteolysis. In this regard, short peptides that inhibit NEMO oligomerization and others designed to inhibit NEMO binding to IKKa and IKKb, successfully blocked bone erosion and osteolysis in various animal models of experimental arthritis and calvarial osteolysis [12] [13] [14] [15] [16] . However, we recently reported that constitutively active IKKb (i.e. IKKbSSEE) induced cytokine-independent osteoclastogenesis in vitro and osteolysis in vivo [17, 18] . Remarkably, this action was refractory to treatment with the above mentioned inhibitory and decoy peptides, suggesting that inhibitory strategies targeting IKKb-proximal moieties, including NEMO and receptor-ligand interactions, are ineffective in this case. Therefore, the need for molecular approaches targeting IKKb directly is essential. In this regard, we have recently reported that intact tyrosine residues 188/199 are absolutely essential for activation of IKKb [19] . In fact mutating these two tyrosine residues was sufficient to attenuate the constitutive activity of IKKbS-SEE. In the current study, we targeted yet another regulatory element in IKKb, namely the ubiquitin-like domain (ULD) of IKKb. To this end, we provide evidence that deletion of ULD attenuates the kinase activity of IKKb and IKKbSSEE. Consistently, ULD-mutated IKKb/ IKKbSSEE failed to reconstitute the osteoclastogenic potential of IKKb-null precursor cells, effectively inhibited osteoclastogenesis by wild type cells, and markedly blocked inflammatory osteolysis in mice.
Material and Methods

Reagents
Antibodies were purchased from Santa Cruz Biotech (Santa Cruz, CA) and Cell Signaling Technologies, Inc. (Danvers, MA). Chemicals were purchased from Sigma (St. Louis, MO). pMx retroviral expression plasmid was from Dr.
T. Kitamura (University of Tokyo, Japan). Mouse cDNA for IKKb was purchased from ATCC.
Animals
Wild type C57BL/6 mice at 5-6 weeks of age were used. All mice were housed in a controlled barrier facility at Washington University (St. Louis, MO). Generation of IKKb-null mice was previously described [20] .
Generation of Retrovirus
All expression constructs were subcloned into pMx using standard techniques. Generation of the various IKKb deletion/mutant constructs was previously described [18] . The use of Plat-E retrovirus packaging cells stably expressing retroviral structural proteins gag-pol and env for transient production of high titer retrovirus was described previously [21] . Briefly, 8 lg pMx vectors expressing gene of interest were transfected into 5 million plat-E cells (grown in DMEM supplemented with 10 % FBS and penicillin/streptomycin) using Fugene 6 (Roche, Palo Alto, CA) according to manufacturer's instructions. Twenty-four hours after transfection, media was exchanged to remove transfection reagent. Twenty-four and 48 h after media exchange, supernatant was collected and pooled for transduction of monocytes.
Generation of Adenovirus
Adenovirus expressing IKKb was generated by subcloning from the pMx parental vector into Ad5 CMV K-NpA Shuttle using EcoR1 and Not1 restriction endonucleases (New England Biolabs, Ipswich, MA). Recombination [22] , production and characterization (pfu/particle) of virus was provided by Viraquest, Inc. (North Liberty, IA). For local in vivo gene transfer in mice, 1 9 10 7 pfu of virus diluted in 50 ll sterile PBS were injected over the supracalvarially. Six mice were utilized for these experiments with comparable results. LPS (10 lg) diluted in 50 ll total volume with PBS was injected supracalvarially.
In vivo injections were executed with 1.00 ml insulin syringes with 29-gauge needles. Seven days after injection calvaria were fixed, decalcified, and analyzed histologically for osteoclasts and osteolysis.
Generation of Monocyte/ Macrophages (Osteoclast Progenitors)
Marrow was flushed from long bones into alpha-minimum essential medium (MEM). Cell pellets were resuspended in whole media [a-MEM with 19 penicillin/streptomycin, 10 % heat-inactivated fetal bovine serum (FBS)]. Monocytes/ macrophages were produced by growing cell suspensions in the presence of 10 ng/ml M-CSF. Monocytes/ macrophages were allowed to proliferate for 3 days at 37°C in 5 % CO 2 at which point they were infected with retrovirus (50 % virus supernatant, 50 % a-MEM containing 10 % FBS, 10 ng/ml M-CSF, penicillin/streptomycin, and 4 lg/ml hexadimethrine bromide). Twenty-four hours after transduction, cells were selected in a-MEM containing 10 % FBS, 10 ng/ml M-CSF, penicillin/streptomycin, and 2 lg/ml puromycin for 72 h, at which point selection media was removed, cells were washed, and grown for an additional 24 h without puromycin. At this point, cells were lifted, counted, and plated per experimental conditions.
In Vitro Osteoclastogenesis
Monocytes were plated in 200 ll a-MEM at 3 9 10 4 with 10 % FBS per well. IKKb expressing cells were cultured in 10 ng/ml recombinant mouse M-CSF (R&D Systems), plus recombinant mouse 100 ng/ml RANKL (R&D Systems) for 4 days. At this point, cells were fixed and TRAP stained using the Leukocyte Acid Phosphatase Kit (Sigma, St. Louis, MO). TRAP-positive cells with three or more nuclei were scored as osteoclasts.
Kinase Assay
Plat E cells expressing indicated flag-tagged IKKb constructs were lysed in immunoprecipitation (IP) buffer (50 mM Tris (pH 8), 120 mM NaCl, 0.5 % NP-40, 50 lg/ml leupeptin, 10 lg/ml aprotinin, 50 lg/ml phenylmethylsulfonyl fluoride (PMSF), 0.2 mM sodium orthovanadate, 100 mM sodium fluorine). IKKb was immunoprecipitated with M2 antibody, washed twice with IP buffer, once with kinase assay buffer (Cell Signaling Technologies Danvers, MA), and incubated for 30 min at 30°C in 30 ll kinase assay buffer with 1 lg GST-IjBa, 2.5 mM MgCl 2 , and 16 lM ATP. Reaction was terminated with 30 ll reducing sample buffer. Samples were analyzed by western blot.
Nuclear Isolation and Electrophoretic Mobility Shift Assay (EMSA)
Cells were resuspended in hypotonic lysis buffer A (10 mM HEPES [pH 7.8] 10 mM KCl, 1.5 mM MgCl, 0.5 mM dithiothreitol 0.5 mM 4-(2-aminoethyl) benzenesulfonyl fluoride (AEBSF), 5 lg/ml Leupeptin) and incubated on ice for 15 min, and NP-40 was added to a final concentration of 0.64 %. Nuclei were pelleted and the cytosolic fraction was carefully removed. The nuclei were then resuspended in nuclear extraction buffer B (20 mM HEPES [pH 7.8] 420 mM NaCl, 1.2 mM MgCl, 0.2 mM EDTA, 25 % glycerol, 0.5 mM dithiothreitol, 0.5 mM AEBSF, 5 lg/ml Pepstatin A, 5 lg/ml Leupeptin), vortexed for 30 s and rotated for 30 min in 4°C. The samples were then centrifuged and the nuclear proteins in the supernatant were transferred to fresh tubes and protein content was measured using standard BCA kit (Pierce, Rockford, IL). A portion of the nuclear extracts (10 lg) was incubated with an endlabeled double stranded oligonucleotide probe containing the sequence 5 0 -AAA CAG GGG GCT TTC CCT CCT C-3
0
[23] derived from the jB3 site of the TNF promoter. The reaction was performed in a total of 20 ll of binding buffer (20 mM HEPES [pH 7.8], 100 mM NaCl, 0.5 mM dithiothreitol, 1 lg poly dI-dC, and 10 % glycerol) for 30 min at room temperature. Samples were then fractionated on a 4 % polyacrylamide gel and visualized by exposing dried gel to film. Another portion of the nuclear extracts was mixed with sample loading buffer and subjected to Western blot to detect p65 nuclear expression.
Histology
Calvarial bones were collected from C57BL/6 mice experimental groups and fixed in 10 % buffered formalin for 24 h. Bones were then decalcified for 7 days in buffer consisting of (14 % (w/v) EDTA, H 4 NOH pH 7.2), dehydrated in ethanol (30-70 %), cleared through xylene, and embedded in paraffin. Sections were stained histochemically for TRAP to visualize osteoclasts. Immunohistochemistry was performed according to manufacturer's instructions for immunoperoxidase staining.
Microscopy
Cells and histological sections were imaged under white or ultraviolet light on an inverted microscope (Olympus IX-51). Digital images were captured using a CCD camera (Olympus DP70, 12 mega-pixel resolution).
Statistical Analysis
Results are representative of at least four independent experiments with similar findings. ANOVA was conducted for comparison between means of various treatment groups. Results are reported as p values.
Results
IKKbDULD Is a Dominant-Negative Inhibitor of NF-jB
IKKb is crucial for activation of NF-jB. We recently described that constitutive activation of IKKb in myeloid cells causes spontaneous osteoclastogenesis in vitro and leads to the development of pathologic osteolysis in mice [17] . Therefore, we examined the functional role of IKK motifs to regulate the function of this kinase. To this end, we cloned full-length (wild type) and ULD-deleted forms of IKKb (referred to as IKKbDULD) in a retroviral plasmid (pMx) to enable transduction in osteoclast precursors (Fig. 1a) . First, we confirmed that both constructs are retrovirally expressed in osteoclast precursors (Fig. 1b) . Consistent with previous findings [24, 25] , we found that deletion of the ubiquitin-like domain in IKKb reduced the catalytic activity of the kinase (Fig. 2a, b ) evident by failure of IKKbDULD to induce activation of its downstream target p65, and failure to phosphorylate IjB in vitro.
In contrast, WT-IKKb was able to phosphorylate IjB and lead to nuclear accumulation of p65 as expected. Consistent with these results, using gel shift mobility assay, we also document that whereas WT-IKKb induced DNA binding activity of NF-jB in response to RANKL within 10 min, no such binding was observed in the presence of IKKbDULD (Fig. 2c) , suggesting that this mutated form of IKKb is a potent dominant negative inhibitor of NF-jB activation.
IKKbDULD Inhibits Osteoclastogenesis In Vitro
NF-jB is crucial for osteoclast differentiation and survival. We and others have shown that IKKb plays a crucial role in this process and that deletion of IKKb from early osteoclast progenitors impedes osteoclastogenesis [20, 26] . Therefore, we examined the role of IKKbDULD in osteoclastogenesis.
To this end, progenitors were transduced with WT-IKKb or IKKbDULD. Super-repressor IjB (SR-IjB), which we have demonstrated previously that it acts as a potent dominant-negative inhibitor of osteoclastogenesis [27, 28] , was included as a control. The results depicted in Fig. 3 show that whereas WT-IKKb elevates (also refer to panel B), IKKbDULD strongly inhibits osteoclastogenesis. The latter response was indistinguishable from the expected dominant negative effect of the SR-IjB.
To further examine the negative osteoclastogenic effect of IKKbDULD we utilized IKKb-null (KO) precursor cells. These cells do not generate osteoclasts [20] . We transduced these IKKb-null cells with GFP, WT-IKKb, catalytically deficient IKKb (IKKb-KM), constitutively active IKKb (IKKb-SSEE), or IKKbDULD. Cells were then treated with RANKL and M-CSF for 4 days and osteoclastogenesis was assessed. The results (Fig. 4a, b) indicate that WT-IjB restored osteoclastogenesis by null cells to levels comparable with wild type cells. The catalytically dead kinase failed whereas the constitutively active kinase restored osteoclastogenesis higher than wild type levels, as we expected. Consistent with its antiosteoclastogenic role, IKKbDULD failed to restore osteoclasts by IKKb-null precursors. 2 IKKbDULD is catalytically inactive and does not activate NFjB. IKKb-null osteoclast precursors were infected with retroviral (pMx) WT-IKKb or ULD-deleted IKKb form. Cells were then treated with RANKL as indicated. Cytosolic and nuclear fractions were isolated and subjected to Western blot testing to detect input material (b-actin) and nuclear p65 expression, respectively (a). Cells as described in (a) were immunoprecipitated with anti-IKKb antibody. The immunoprecipitate was then subjected to in vitro kinase assay using recombinant GST-IjB as a substrate to demonstrate in vitro phosphorylation (b). Nuclear extracts isolated from same cells described in (b) were subjected to NF-jB electrophoretic mobility gel shift assay (c). NS nonspecific binding IKKbDULD Blocks Inflammatory Osteolysis in Mice NF-jB pathway mediates inflammatory and osteolytic responses. Our previous work has shown that inhibition of NF-jB at various stages attenuates murine osteolysis [12, 13, 16, 27, 29, 30] . Thus, based on our in vitro observations, we surmised that IKKbDULD is a promising tool to inhibit inflammatory osteolysis. To test this possibility, lipopolysaccharide (LPS) injections (10 lg) were administered locally over the calvaria in the presence of vehicle or adv-IKKbDULD. As expected, LPS caused a severe osteolytic response (Fig. 5) evident by generation and recruitment of mass numbers of TRAP-positive osteoclasts and subsequent bone erosion (arrows). Consistent with its proposed antiosteolytic role, virally produced IKKbDULD completely blocked the LPS-mediated osteolytic response (Fig. 5a, b) and significantly reduced the number of osteoclasts at the resorptive site (Fig. 5c ).
Discussion
The osteoclastogenic roles of various molecules in the NFjB pathway have been described. Furthermore, it was shown that components of the classical NF-jB pathway, dominated by IKKb, as well as components of the alternative NF-jB pathway contribute to osteoclast formation and activity [4, 9, 31] . In addition, the classical NF-jB pathway mediates wide range of inflammatory pathways [26, 32, 33] . Indeed, ample evidence point to a central role of IKKb in inflammatory bone diseases and position this kinase as an attractive target for osteolytic bone therapies.
The most compelling evidence for IKKb regulation of osteolysis was evident from our recent discovery that constitutively active IKKb heightened osteoclastogenesis in vitro and in vivo, and caused severe bone loss in transgenic mice [17, 18] . This effect of constitutively active IKKb was independent of proximal stimuli including RANKL, TNF and IL-1 signaling. Even more surprisingly, the osteoclastogenic action of this active form of IKKb was independent of proximal NF-jB component most notably its immediate partners IKKa and NEMO. In fact, administration of NEMO-binding domain decoy peptide, which we have demonstrated previously as potent inhibitor of NF-jB and osteoclasts, failed to impact the activity of constitutively active IKKb.
The potent IKKb independent osteoclastogenic effect was further verified in vivo. In this regard, using tissuespecific knock-in approach, we expressed the constitutively active form of IKKb in the myeloid lineage. Mice harboring this IKKb form presented significant bone loss [17] .
The observations described herein suggest that inflammatory osteolysis secondary to constitutively active IKKb may be refractory to therapeutic modalities aimed at proximal RANK/RANKL and NF-jB signaling targets. Therefore, there is a need to explore IKKb intrinsic regulatory elements to modulate its activity. In this regard, we reported recently that tyrosine phosphorylation of IKKb at residues Y188/Y199 is a prerequisite for its activation and that mutation of one or both tyrosine residues renders IKKb inactive [19] . More importantly, this mutant form of IKKb acts as a dominant negative inhibitor of NF-jB and osteoclastogenesis.
The ubiquitin-like domain of IKKb was first reported as negative regulator of its kinase activity [24] . In the present study, we examined the physiological relevance of IKKb- Fig. 3 IKKbDULD inhibits osteoclastogenesis. a Osteoclast precursors were infected with control (pMx alone), WT-IKKb, IKKbDULD, or superrepressor IjB (SR-IjB). Cells were then cultured in the presence of RANKL and M-CSF for 4 days, fixed and stained with TRAP. b Osteoclasts were counted from quadruple wells and 3 independent experiments representative of (a). Statistical analyses comparing IKKbDULD with control and SR-IjB with control, p value \0.05 for both ULD. We show that deletion of ULD abolishes the kinase activity of IKKb in vitro evident by its inability to phosphorylate its immediate target protein IjBa. Consequently, ULD-deficient IKKb not only fail to activate NF-jB but also acts as a dominant-negative inhibitor blocking activation of endogenous IKKb in response to RANKL stimulation of marrow macrophages. Given the established role of IKKb in osteoclastogenesis, we examined the effect of IKKbDULD in this setting. Consistently, IKKbDULD inhibited osteoclastogenesis as efficiently as SR-IjB did. In addition, unlike the wild type and constitutively active forms of the kinase, IKKbDULD failed to restore osteoclastogenesis when introduced into IKKb-null cells treated with RANKL, just as the kinase-dead form, IKKb-KM, failed.
Finally, the functional relevance of IKKbDULD was tested in vivo, using an inflammatory osteolytic mouse model that we have established previously. Specifically, we have tested the potential anti-osteolytic activity effect of virally produced IKKbDULD in LPS-induced murine calvarial osteolysis. The findings clearly support the notion that IKKbDULD is a potent inhibitor of inflammatory osteolysis and present a potential therapeutic utility. It should be noted, however, that the short duration of the experiment (1 week) does not permit definitive conclusion as to potential adverse effects. Given that the ULD peptide alone was reportedly sufficient to inhibit TNF-induced NFjB activity [24] , we anticipate that administration of this short peptide, similar to NBD, will be more effective owing to lesser potential immunogenicity and easier application.
The exact mechanism by which ULD inhibits NF-jB and osteoclastogenesis remains unclear. However, the overall findings point to inactivity of IKK2. This inactivity does not stem from failure to assemble an IKK complex but possibly due to interference with the activation T loop following conformational change. This is somewhat supported by our unpublished observations whereby deletion of ULD ablates the kinase activity of the constitutively active form of IKK2, namely IKK2SSEE. Further experiments are required to establish the underpinning mechanism.
Signal-induced mono-ubiquitination of IKK2 at lysine 163 was previously described by Carter and colleagues [34, 35] . This report also describes regulation of phosphorylation of the activation T loop by ubiquitination. The physiological significance of this lysine 163 ubiquitination in osteoclastogenesis and inflammatory osteolysis, if any, remains unclear. Fig. 5 IKKbDULD is a potent inhibitor of calvarial inflammatory osteolysis. Adenoviral particles of IKKbDULD (1 9 10 7 pfu) and LPS (10 lg) were administered over the calvaria of mice separately or in combination at day 0 and every 2 days thereafter. Calvaria were collected on day 7 and processed for immunostaining (a) and histomorphometric (b, c) analysis. S midsagittal suture. Arrows indicate osteolysis and osteoclasts (red staining). Control mice were injected with PBS. b Average of osteolytic area (lm 2 ) from 3 independent experiments measured by Osteomeasure software [36] . *, ** p \ 0.005 compared as indicated by lines. c Number of osteoclasts per surface area as described previously [36] , representing the average of 3 independent experiments. * p \ 0.005, ** p \ 0.01 b
